Catalog No. : |
CLP1113 |
Product Name : |
Cagrilintide |
CAS No. : |
1415456-99-3 |
Synonyms : |
|
Chemical Name : |
Sequence {Eicosanedioic acid-γ-Glu}-Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Glu-Phe-Leu-Arg-His-Ser-Ser-Asn-Asn-Phe-Gly-Pro-Ile-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Pro-NH2 (Disulfide bridge:Cys3-Cys8) |
Molecular Formula : |
C194H312N54O59S2 |
Molecular Weight : |
4409.01 |
Molecular Structure : |
|
Appearance : |
White to off-white powder |
Specification : |
98+% |
Application : |
Research on the treatment of diabetes | CGRP Receptor |
Registration : |
|
Storage Condition : |
Dry, dark and at -20 ℃ for 1 year or -80 ℃ for 2 years |
Cagrilintide, an investigational novel long-acting acylated amylin analogue, functions as an agonist for nonselective amylin receptors (AMYR) and the calcitonin G protein-coupled receptor (CTR). It significantly reduces food intake and induces weight loss, showing promise for obesity research.
Statement:
->>Products covered by valid patents are not offered or supplied for commercial use.
->>Products currently covered by valid US Patents are offered for laboratory R&D use in accordance with 35 USC 271(e)+A13(1).
->>Any patent infringement and resulting liability is solely at buyer's risk.
->>Our products are only raw materials for drugs or industry, can't be used for human or animals directly.